TrialNature communications2026

Demethylation-primed tandem CD19/CD20 CAR T cells in relapsed/refractory B-cell lymphoma: a phase I/II trial.

Chunmeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.